For a long time, traditional approaches often focused solely on diet and exercise, which, while vital, frequently fell short for individuals whose biology and metabolism were working against them
After years of research on this compound, l-carnitine is now considered a quasi-vitamin because for most people the human body can produce enough l-carnitine itself
Recent evidence showed that Tirzepatide (TZP), a new drug including both Glucagon Like Peptide 1 (GLP-1) and Glucose-dependent Insulinotropic Polypeptide (GIP) receptor agonism, is effective in subjects with type 2 diabetes (T2D), lowering body weight, fat mass and glycated hemoglobin (HbA 1c ) also in obese or overweight adults without T2D
Huertas R, Campos Y, Daz E, Esteban J, Vechietti L, Montanari G, D'Iddio S, Corsi M, Arenas J: Respiratory chain enzymes in muscle of endurance athletes: effect of L-carnitine
324,325 SREBP-1c is a major regulator of fatty acid synthesis and hepatic SREBP-1c overexpression increases DAG content and PKC translocation that in turn impairs INSR tyrosine kinase activity, thereby inducing hepatic IR
they target different points in a chain